In a different approach, NP encapsulating CTLA-4 siRNA showed a decrease in CTLA-4 expression and a suppression of tumor growth after systemic administration in a B16 melanoma mouse tumor model (Li et al., 2016). The gene discussed is CTLA4; the disease is neoplasm.